Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2008
08/19/2008US7413851 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
08/19/2008US7413850 Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis
08/19/2008US7413739 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
08/19/2008US7413735 Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
08/19/2008US7413712 Multicompartment biochip device for use in amplifing preferential nucleotide sequenes; gene expression analysis
08/19/2008US7413708 Methods and reagents for combined PCR amplification
08/19/2008US7413706 Replaceable parylene membranes for nanocalorimeter
08/19/2008US7413640 Foldable, electric-current conductivity biosensor
08/19/2008US7412990 Microfluidic control device and method for controlling microfluid
08/19/2008CA2387283C Biosensor
08/19/2008CA2374588C Mathematical analysis for the estimation of changes in the level of gene expression
08/19/2008CA2334269C Diagnostic assay requiring a small sample of biological fluid
08/19/2008CA2286775C Chemical indicator and its use
08/19/2008CA2151801C 3'-modified oligonucleotide derivatives
08/19/2008CA2118913C Nucleic acids extension assay
08/14/2008WO2008098256A1 Methods for identifying patients with an increased likelihood of responding to dpp-iv inhibitors
08/14/2008WO2008098248A2 Particles for detecting intracellular targets
08/14/2008WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins
08/14/2008WO2008098208A2 Gnaq mutations in melanoma
08/14/2008WO2008098159A2 Genetic marker for risk of cardiovascular disorder
08/14/2008WO2008098142A2 Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
08/14/2008WO2008098100A2 Detection of molecule proximity
08/14/2008WO2008097957A2 Detection of mature small rna molecules
08/14/2008WO2008097929A2 Engineered toehold reactions and networks
08/14/2008WO2008097887A2 Methods of direct genomic selection using high density oligonucleotide microarrays
08/14/2008WO2008097773A1 Methods and devices for diagnosis of appendicitis
08/14/2008WO2008097632A2 Methods for determining splice variant types and amounts
08/14/2008WO2008097585A2 Mutations in human ubiad1
08/14/2008WO2008097582A2 Fluorescent single chain antibody (sc-fv) and its use in detection of analytes
08/14/2008WO2008097543A2 Gene methylation in cancer diagnosis
08/14/2008WO2008097349A2 Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes
08/14/2008WO2008097340A2 Methods of detecting dna n-glycosylases, methods of determining n-glycosylase activity, and n-glycolsylase assay kits
08/14/2008WO2008097328A2 Asymmetric functionalized nanoparticles and methods of use
08/14/2008WO2008097277A2 Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
08/14/2008WO2008097268A2 Apparatus and method for detection of trace chemicals
08/14/2008WO2008097261A2 Single walled carbon nanotubes with functionally adsorbed biopolymers for use as chemical sensors
08/14/2008WO2008097190A1 Methods of electrically detecting a nucleic acid by means of an electrode pair
08/14/2008WO2008097082A1 Method for the detection of chlamydia trachomatis and a kit for it
08/14/2008WO2008096923A1 Methods for fabrication of uncultivated genome-probing microarrays by amplifying genome derived from a single microbial cell using multiple displacement amplification
08/14/2008WO2008096842A1 Method for screening of substance for prevention or treatment of degenerative disease
08/14/2008WO2008096817A1 Gaba neuron progenitor cell marker 65b13
08/14/2008WO2008096745A1 Method for production of hair and biomaterial
08/14/2008WO2008096375A2 Genetic variants contributing to risk of prostate cancer
08/14/2008WO2008096177A2 Detection of human papillomavirus
08/14/2008WO2008096146A1 Preparation of templates for methylation analysis
08/14/2008WO2008096009A2 Polymorphism in the slc30a8 gene
08/14/2008WO2008095907A1 Methods and kits for determining drug sensitivity in patients infected with hcv
08/14/2008WO2008095735A1 Use of sirt7 for treating age-related diseases
08/14/2008WO2008095730A2 Method for identifying an active ingredient complex, which modifies an enzymatic property of a synaptosomal / synaptic site of action complex in the region of a synaptosomal / synaptic membrane, biosensor arrangement, device for amperometric and/or potentiometric pharmacological site of action and/or active ingredient testi
08/14/2008WO2008095680A1 Method for discriminating single nucleotide polymorphisms (snps)
08/14/2008WO2008095493A1 Reporter unit for detection of target molecules using polymerisable substrate
08/14/2008WO2008095492A2 A method for diagnosing atherosclerotic plaques by measurement of cd36
08/14/2008WO2008095357A1 Treatment for spinal muscular atrophy
08/14/2008WO2008095356A1 Methods of diagnosis of spinal muscular atrophy and treatments thereof
08/14/2008WO2008095296A1 Class ii histone deacetylase whole cell enzyme assay
08/14/2008WO2008095261A1 Method of diagnosing a neurodegenerative disease
08/14/2008WO2008095222A1 Homogeneous in vitro fec assays and components
08/14/2008WO2008080029A9 Methods and compositions for nucleic acid amplification
08/14/2008WO2008067102A3 Biomarkers of cancer risk and their use in cancer detection and prevention
08/14/2008WO2008066624A3 Dna damage repair inhibitors and methods for treating cancer
08/14/2008WO2008054543A3 Oligonucleotides for multiplex nucleic acid assembly
08/14/2008WO2008051857A3 Nuclear magnetic resonance method for quantitative and qualitative measurement of natural products
08/14/2008WO2008049039A3 Assay system for adenosine triphosphate and creatine kinase
08/14/2008WO2008034648A8 Process for the production of a fine chemical
08/14/2008WO2008008846A3 Differential expression of molecules associated with intra-cerebral hemorrhage
08/14/2008WO2008006105A3 Genetic markers in the tachykinin nk1 receptor (tacr1) gene that correlate with asthma disorders
08/14/2008WO2008006104A3 Enhanced oxygen cell culture platforms
08/14/2008WO2008002672A3 Targets for use in diagnosis, prognosis and therapy of cancer
08/14/2008WO2008002548A3 Novel human acidic mammalian chitinase and use thereof
08/14/2008WO2007134384A3 Selective modulation of receptor signalling
08/14/2008WO2007131202A3 Genomics of in-stent restenosis
08/14/2008WO2007129182A3 Microorganisms detection and enumeration method
08/14/2008WO2007120362A3 Adipogenic adenoviruses as a biomarker for disease
08/14/2008WO2007109293A3 Early diagnosis of congenital abnormalities in the offspring of diabetic mothers
08/14/2008WO2007102869A3 Treatment of ovarian cancer with clostridium perfringens enterotoxin
08/14/2008WO2007079428A3 Promoter engineering and genetic control
08/14/2008WO2007079351A3 Novel prime-boost combinations of attenuated mycobacterium
08/14/2008WO2007078806A3 Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine
08/14/2008WO2007075924A3 Methods and applications of molecular beacon imaging for infectious disease and cancer detection
08/14/2008WO2007067803A3 Diagnostic targets against johne's disease
08/14/2008WO2004064783A3 Eosinophil-derived neurotoxin as a marker for ovarian cancer
08/14/2008US20080196127 Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
08/14/2008US20080196120 Genes Involved in Plant Fibre Development
08/14/2008US20080196113 Lipocalin Protein
08/14/2008US20080196112 Using vector transformation to generate cells for use as bioreactor to prepare/express humanized antibodies
08/14/2008US20080196111 Expression Vectors and Methods for Obtaining Nk Cell Specific Expression
08/14/2008US20080195326 Method And System For Comprehensive Knowledge-Based Anonymous Testing And Reporting, And Providing Selective Access To Test Results And Report
08/14/2008US20080195324 Computer comprising three-dimensional coordinates of a yeast RNA polymerase II
08/14/2008US20080195323 Quality assurance for high-throughput bioassay methods
08/14/2008US20080194990 Integrated Lancing And Measurement Device And Analyte Measuring Methods
08/14/2008US20080194711 determining the level of expression of chemokine receptor (CX3CR1) genes or protein expression in natural killer cells; reduction of the relative expression is indicative of nervous system disorders; medical diagnosis
08/14/2008US20080194710 Prostatic Stem Cells, Isolation and Uses
08/14/2008US20080194701 DNA molecules isolated from Streptococcus agalactiae, comprising genes responsible for gamma -glutamyl-L-cysteinylglycine synthesis; drug design; treatment of infections caused by streptococcus agalactiae
08/14/2008US20080194636 Controlling insulin aminiopeptidase; cognition activators; induction labor and lactation; side effecxt reduction
08/14/2008US20080194613 P53 Wild-Type as Biomarker for the Treatment with Mtor Inhibitors in Combination With a Cytotoxic Agent
08/14/2008US20080194522 Substituted benzopyran-2-ones; competitive binding ligands for MAO inhibition; anxiolytic agents; neurodegenerative diseases, nervous system disorders; drug screening by comparing detectable changes in fluorescence when samples are oxidatively deaminated in the presence of a MAO
08/14/2008US20080194515 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening
08/14/2008US20080194509 Novel Adenyl Dinucleotides with Antitumour Activity and a Method of preparing Thereof
08/14/2008US20080194508 Cell Counting
08/14/2008US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay
1 ... 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 ... 3003